This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07470/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07470/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07470/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07470/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07470
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07470 n12:DB07470
dcterms:title
(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one
adms:identifier
n4:24178121 n7:DB07470 n11:99443941 n13:BL7
n5:IUPAC-Name
n6:271B476D-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4773-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4772-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B476F-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4770-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4771-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B476B-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B476C-363D-11E5-9242-09173F13E4C5 n6:271B4769-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B476A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4779-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B477A-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4774-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4775-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4777-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4776-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4778-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B477F-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4781-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4782-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B477E-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B477D-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4780-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B476E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B477B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B477C-363D-11E5-9242-09173F13E4C5